14 results on '"Hulbert, Monica L."'
Search Results
2. Education Liaison improves implementation of school accommodations for students with sickle cell disease.
- Author
-
McGlynn MC, Gilliam A, Pierson SK, and Hulbert ML
- Subjects
- Child, Humans, Retrospective Studies, Educational Status, Schools, Students, Anemia, Sickle Cell therapy, Anemia, Sickle Cell psychology
- Abstract
Background: Children with sickle cell disease (SCD) have lower academic attainment than healthy peers. Many benefit from neuropsychological testing (NPT) and educational accommodations, including Individualized Education Programs (IEPs) and Section 504 plans (504s). Despite medical barriers to academic attainment, many children with SCD do not receive indicated NPT or accommodations., Objective: We hypothesize that a dedicated Education Liaison (EL) embedded in the SCD team increases implementation of NPT and accommodations., Study Design: This retrospective study included children aged 5-20 years with SCD receiving care at a single center from 2017 through 2020. Univariate analysis and multiple logistic regression were performed., Results: Total 316 children with SCD were included. At baseline, 52.8% had accommodations (IEP: 24.4%, 504: 38.0%). The EL interacted with 62.0% of children. Children with EL contact were more likely to undergo NPT (odds ratio [OR]: 5.385), have an IEP (OR: 4.580), and have a 504 (OR: 2.038) (p < .001 for all). At the end of the study period, 64.6% had accommodations (IEP: 33.5%, 504: 54.4%), which increased from baseline (p < .001 for all). EL interaction was associated with overt or silent stroke history (OR: 1.911), acute chest syndrome history (OR: 2.257), hospitalizations since age 5 (OR: 3.216), and hospitalization for vaso-occlusive pain since age 5 (OR: 2.226) (p < .001 for all)., Conclusion: EL interaction improves access to NPT and educational accommodations among children with SCD. SCD centers should incorporate ELs in comprehensive care teams to improve access to appropriate educational accommodations., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
3. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
- Author
-
Aldana PR, Hanel RA, Piatt J, Han SH, Bansal MM, Schultz C, Gauger C, Pederson JM, Iii JCW, Hulbert ML, Jordan LC, Qureshi A, Garrity K, Robert AP, Hatem A, Stein J, Beydler E, Adelson PD, Greene S, Grabb P, Johnston J, Lang SS, Leonard J, Magge SN, Scott A, Shah S, Smith ER, Smith J, Strahle J, Vadivelu S, Webb J, and Wrubel D
- Subjects
- Humans, Child, Retrospective Studies, Prospective Studies, Treatment Outcome, Moyamoya Disease etiology, Cerebral Revascularization adverse effects, Cerebral Revascularization methods, Stroke etiology, Anemia, Sickle Cell complications
- Abstract
Background: Recent studies suggest that cerebral revascularization surgery may be a safe and effective therapy to reduce stroke risk in patients with sickle cell disease and moyamoya syndrome (SCD-MMS)., Methods: We performed a multicenter, retrospective study of children with SCD-MMS treated with conservative management alone (conservative group)-chronic blood transfusion and/or hydroxyurea-versus conservative management plus surgical revascularization (surgery group). We monitored cerebrovascular event (CVE) rates-a composite of strokes and transient ischemic attacks. Multivariable logistic regression was used to compare CVE occurrence and multivariable Poisson regression was used to compare incidence rates between groups. Covariates in multivariable models included age at treatment start, age at moyamoya diagnosis, antiplatelet use, CVE history, and the risk period length., Results: We identified 141 patients with SCD-MMS, 78 (55.3%) in the surgery group and 63 (44.7%) in the conservative group. Compared with the conservative group, preoperatively the surgery group had a younger age at moyamoya diagnosis, worse baseline modified Rankin scale scores, and increased prevalence of CVEs. Despite more severe pretreatment disease, the surgery group had reduced odds of new CVEs after surgery (odds ratio = 0.27, 95% confidence interval [CI] = 0.08-0.94, p = .040). Furthermore, comparing surgery group patients during presurgical versus postsurgical periods, CVEs odds were significantly reduced after surgery (odds ratio = 0.22, 95% CI = 0.08-0.58, p = .002)., Conclusions: When added to conservative management, cerebral revascularization surgery appears to reduce the risk of CVEs in patients with SCD-MMS. A prospective study will be needed to validate these findings., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
4. Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
- Author
-
Hulbert ML, Manwani D, Meier ER, Alvarez OA, Brown RC, Callaghan MU, Campbell AD, Coates TD, Frei-Jones MJ, Hankins JS, Heeney MM, Hsu LL, Lebensburger JD, Quinn CT, Shah N, Smith-Whitley K, Thornburg C, and Kanter J
- Subjects
- Child, Humans, Consensus, Anemia, Sickle Cell therapy
- Abstract
Sickle cell disease (SCD) requires coordinated, specialized medical care for optimal outcomes. There are no United States (US) guidelines that define a pediatric comprehensive SCD program. We report a modified Delphi consensus-seeking process to determine essential, optimal, and suggested elements of a comprehensive pediatric SCD center. Nineteen pediatric SCD specialists participated from the US. Consensus was predefined as 2/3 agreement on each element's categorization. Twenty-six elements were considered essential (required for guideline-based SCD care), 10 were optimal (recommended but not required), and five were suggested. This work lays the foundation for a formal recognition process of pediatric comprehensive SCD centers., (© 2022 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
5. Still seeking balance in opioid management for acute sickle cell disease pain.
- Author
-
Fasipe TA and Hulbert ML
- Subjects
- Analgesics, Opioid therapeutic use, Humans, Acute Pain drug therapy, Acute Pain etiology, Anemia, Sickle Cell complications, Anemia, Sickle Cell drug therapy
- Published
- 2022
- Full Text
- View/download PDF
6. Epstein-Barr virus-induced sickle hepatopathy.
- Author
-
Towerman AS, Wilson DB, and Hulbert ML
- Subjects
- Adolescent, Female, Herpesvirus 4, Human, Humans, Male, Anemia, Sickle Cell complications, Cholestasis, Intrahepatic etiology, Epstein-Barr Virus Infections complications, Hemoglobin SC Disease complications
- Abstract
Sickle hepatopathy comprises a spectrum of disorders that vary in severity. Intravascular sickling and sinusoidal occlusion are the principal drivers of sickle hepatopathy, but infection or autoimmunity can act as triggers. We describe two cases of acute sickle hepatopathy initiated by primary Epstein-Barr virus (EBV) infection, a previously unreported association. The first case entailed a 14-year-old girl with hemoglobin SC (HbSC) disease who developed hepatic sequestration crisis that responded to a simple transfusion of erythrocytes. The second case was that of a 16-year-old boy with HbSC disease who experienced life-threatening intrahepatic cholestasis with multiorgan failure., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
7. Sickle cell disease-Under pressure.
- Author
-
Halabi CM and Hulbert ML
- Subjects
- Humans, Anemia, Sickle Cell
- Published
- 2021
- Full Text
- View/download PDF
8. Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease.
- Author
-
Hood AM, King AA, Fields ME, Ford AL, Guilliams KP, Hulbert ML, Lee JM, and White DA
- Subjects
- Adolescent, Child, Female, Humans, Male, Young Adult, Anemia, Sickle Cell therapy, Blood Transfusion, Executive Function
- Abstract
Individuals with sickle cell disease (SCD) experience cognitive deficits; however, it remains unclear whether medical treatments for SCD improve cognition. Given that executive abilities are typically impaired in individuals with SCD, they were the focus of the current study. Our primary hypothesis was that executive abilities would be higher acutely soon after a blood transfusion in children and young adults with SCD. We used tests from the NIH Toolbox to assess executive abilities in 27 participants with SCD receiving chronic transfusion in comparison to 34 participants with SCD receiving hydroxyurea (HU) and 41 non-SCD demographically matched controls, all of whom were tested at two time points. Participants in the transfusion group completed cognitive testing within 3 days after a transfusion (soon after transfusion) and then within 3 days before their next transfusion (long after transfusion) over an interval of 3-7 weeks. We found that executive abilities were significantly poorer for the transfusion and HU groups than for the control group. In support of our primary hypothesis, executive abilities for the transfusion group were significantly better soon after a transfusion compared to long after a transfusion, χ
2 (1) = 17.8, P < .0001. Our results demonstrate that executive abilities were higher acutely following a blood transfusion. These findings have implications for daily functioning, medical decision making, and academic achievement in children and young adults with SCD., (© 2019 Wiley Periodicals, Inc.)- Published
- 2019
- Full Text
- View/download PDF
9. Prevalence and nature of hearing loss in a cohort of children with sickle cell disease.
- Author
-
Towerman AS, Hayashi SS, Hayashi RJ, and Hulbert ML
- Subjects
- Adolescent, Adult, Audiometry, Child, Child, Preschool, Female, Follow-Up Studies, Hearing Loss etiology, Humans, Infant, Infant, Newborn, Male, Missouri epidemiology, Prevalence, Prognosis, Retrospective Studies, Young Adult, Anemia, Sickle Cell complications, Hearing Loss classification, Hearing Loss epidemiology
- Abstract
Background: Sickle cell disease (SCD) may cause injury to any organ, including the auditory system. Although the association of SCD and hearing loss has been described, the nature of this complication is unknown. We sought to establish the prevalence and nature of hearing loss in a referred cohort of children with SCD and to identify correlating disease- or treatment-associated factors., Procedure: We conducted a retrospective review of patients with SCD < 22 years of age who had hearing evaluations between August 1990 and December 2014. Demographics, audiograms, and disease and treatment variables were analyzed., Results: Two hundred and ten audiograms among 81 patients were reviewed, and 189 were evaluable. Seventy-two children constituted the referred cohort. Fourteen (19.4%) had hearing loss documented on at least one audiogram. Seven (9.7%) patients had only conductive hearing loss, and the loss persisted for up to 10.3 years. The median age of first identification was eight years. Six (8.3%) patients had hearing loss that was at least partially sensorineural. One patient's hearing loss was ambiguous. All sensorineural hearing losses were unilateral and 4/6 patients had prior documented normal hearing, indicating acquired loss. No correlations were identified., Conclusions: Both conductive and sensorineural hearing losses are more prevalent in our study population than those observed in the general pediatric population. In children with SCD, sensorineural hearing loss appears to be acquired and unilateral. Conductive hearing loss was identified in older children and can persist. Serial screening is needed for early detection and more prompt intervention in this population., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
10. Hematopoietic stem cell transplantation for sickle cell disease: Progress and challenges.
- Author
-
Hulbert ML and Shenoy S
- Subjects
- Adolescent, Child, Clinical Decision-Making, Clinical Trials as Topic, Combined Modality Therapy, Female, Forecasting, Graft vs Host Disease etiology, Graft vs Host Disease prevention & control, Health Services Accessibility, Humans, Male, Patient Selection, Professional-Patient Relations, Risk, Tissue Donors, Tissue and Organ Procurement, Transplantation Conditioning adverse effects, Transplantation Conditioning methods, Transplantation Conditioning trends, Anemia, Sickle Cell therapy, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cell Transplantation statistics & numerical data, Hematopoietic Stem Cell Transplantation trends
- Abstract
Sickle cell disease (SCD) presents challenges to hematopoietic stem cell transplantation (HSCT), including donor availability and morbidity with age/disease severity. However, severe SCD causes irreversible organ damage that HSCT can mitigate. This benefit must be balanced against preparative regimen toxicity, graft-versus-host disease, and mortality risk. We review efforts to balance HSCT complications with the promise of cure, and knowledge gaps that warrant further investigation. We highlight the burden of SCD, HSCT risks and benefits, and SCD families' approach to this balance. We emphasize the necessity for information exchange to ensure a joint decision-making process between providers and patients., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
11. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
- Author
-
Woods D, Hayashi RJ, Binkley MM, Sparks GW, and Hulbert ML
- Subjects
- Adolescent, Adult, Anemia, Sickle Cell therapy, Child, Child, Preschool, Female, Follow-Up Studies, Hemoglobin, Sickle metabolism, Humans, Male, Prognosis, Retrospective Studies, Young Adult, Anemia, Sickle Cell complications, Erythrocyte Transfusion adverse effects, Exchange Transfusion, Whole Blood adverse effects, Iron Overload etiology
- Abstract
Background: Children and adolescents with sickle cell disease (SCD) are at high risk of strokes and are frequently treated with red blood cell (RBC) transfusions. The goal is to suppress hemoglobin (Hb) S while minimizing transfusion-induced iron overload. RBCs may be given via simple transfusion, manual exchange transfusion (MET), or erythrocytapheresis (aRBCX). Chronic transfusion practices vary among institutions., Methods: This single-institution, retrospective cohort study compares Hb S control and therapy complication rates between MET and aRBCX in a cohort of children and adolescents with SCD and stroke during a 5-year period from 2008 through 2012. Duration and mode of transfusion therapy, achievement of Hb S suppression goal, iron burden by ferritin levels, and catheter complications were evaluated., Results: Thirty-seven children were included in analysis. The prevalence of catheter complications was 75% in aRBCX recipients compared with 0% in MET recipients (P < 0.001). There was no significant difference between modalities in achieving Hb S suppression or ferritin goals, but those receiving aRBCX had a greater likelihood of discontinuing chelation therapy. Among aRBCX recipients, adherence to >90% of transfusion appointments was associated with achieving Hb S suppression goals., Conclusion: aRBCX may have increased complication risks compared with MET for chronic transfusion therapy in SCD. Risks and benefits of aRBCX and MET should be considered when selecting a chronic transfusion modality. Transfusion therapy modalities should be compared in prospective studies for stroke prevention in children with SCD., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
12. Challenges for teens with sickle cell disease extend to mental health.
- Author
-
Hulbert ML
- Subjects
- Adolescent, Humans, Anemia, Sickle Cell, Mental Health
- Published
- 2016
- Full Text
- View/download PDF
13. Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.
- Author
-
Hall EM, Leonard J, Smith JL, Guilliams KP, Binkley M, Fallon RJ, and Hulbert ML
- Subjects
- Anemia, Sickle Cell pathology, Child, Child, Preschool, Cohort Studies, Female, Humans, Ischemic Attack, Transient pathology, Magnetic Resonance Angiography, Male, Moyamoya Disease pathology, Retrospective Studies, Subarachnoid Hemorrhage pathology, Anemia, Sickle Cell therapy, Cerebral Infarction prevention & control, Cerebral Revascularization methods, Moyamoya Disease therapy, Transfusion Reaction
- Abstract
Background: Children with sickle cell disease (SCD) and moyamoya may benefit from indirect cerebral revascularization surgery in addition to chronic blood transfusion therapy for infarct prevention. We sought to compare overt and silent infarct recurrence rates in children with SCD undergoing revascularization., Methods: This was a retrospective cohort study of all children with SCD and moyamoya treated at two children's hospitals. Clinical events and imaging studies were reviewed., Results: Twenty-seven children with SCD and confirmed moyamoya receiving chronic transfusion therapy were identified, of whom 12 underwent indirect cerebral revascularization. Two subjects had postoperative transient ischemic attacks and another had a subarachnoid blood collection, none of which caused permanent consequences. Two subjects had surgical wound infections. Among these 12 children, the rate of overt and silent infarct recurrence decreased from 13.4 infarcts/100 patient-years before revascularization to 0 infarcts/100 patient-years after revascularization (P = 0.0057); the postrevascularization infarct recurrence rate was also significantly lower than the overall infarct recurrence of 8.87 infarcts/100 patient-years in 15 children without cerebral revascularization (P = 0.025)., Conclusions: The rate of overt and silent infarct recurrence was significantly lower following indirect cerebral revascularization. A prospective study of cerebral revascularization in children with SCD is needed., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
14. Children with sickle cell disease need more effective therapies, not more X-rays.
- Author
-
Hulbert ML
- Subjects
- Female, Humans, Male, Anemia, Sickle Cell diagnostic imaging, Tomography, X-Ray Computed adverse effects
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.